Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons - Wikidata - awgldk - TriplyDB

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

http://www.wikidata.org/entity/Q28342691

about

Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction Molecular targets for antiepileptic drug development The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(lh)) and tottering (Cacna1atg) mouse thalami Amiloride and SN-6 suppress audiogenic seizure susceptibility in genetically epilepsy-prone rats TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.T-type voltage-gated calcium channels as targets for the development of novel pain therapies.Continuous spike-waves during slow-wave sleep in a mouse model of focal cortical dysplasia Ion channels and the genetic contribution to epilepsy.Lamotrigine extends lifespan but compromises health span in Drosophila melanogaster.Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy.Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.The pharmacologic basis of antiepileptic drug action.Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.An assessment of the present and future roles of non-ligand gated ion channel modulators as CNS therapeutics.Antiepileptic drug mechanisms of action.The American Epilepsy Society: an historic perspective on 50 years of advances in research.Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs.Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents.Early treatment suppresses the development of spike-wave epilepsy in a rat model Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.New antiepileptic drugs: from serendipity to rational discovery.Aberrant Thalamocortical Synchrony Associated with Behavioral Manifestations in Git1 (-/-) Mice.Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.Therapeutic drug monitoring of old and newer anti-epileptic drugs.The effects of ion channel blockers validate the conductance-based model of saccadic oscillations.Sacred disease secrets revealed: the genetics of human epilepsy.From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway Seizures of idiopathic generalized epilepsies.Amiloride suppresses pilocarpine-induced seizures via ASICs other than NHE in rats.Ethosuximide Affects Paired-Pulse Facilitation in Somatosensory Cortex of WAG\Rij Rats as a Model of Absence Seizure.Activation of mouse sperm T-type Ca2+ channels by adhesion to the egg zona pellucida.Amiloride delays the onset of pilocarpine-induced seizures in rats.Ethosuximide for Essential Tremor: An Open-Label Trial.Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis.Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.

P2860

Q24673531-754EDB02-169D-4402-9CB8-9F7F7F15FC85 Q24683346-24379EE6-3DF4-4643-9E67-54A60F1D5283 Q26781422-7E6DFDFD-DF5A-4548-9DFA-D2974805140C Q27323026-6E8A4578-F909-4504-A701-D01788FC9055 Q28239380-304C712D-5F5D-49D2-8F77-DEFFE9676EE5 Q28272457-2F550166-CCCC-44C3-BA4D-0F9183DF9D68 Q28590366-0DEF1162-8E31-48F7-965C-DD99A6B52E41 Q30403680-D0B19108-5EC9-418B-81A6-A15D2935E9CC Q30424352-970881FA-AF88-42E3-8AB3-086EB78FAF10 Q30426595-13C7EF66-BCB8-4B97-9C15-266E0776883E Q30848115-45B9584E-DCAE-4100-86FF-160926E092EE Q33534658-4B95A743-B445-4FAC-A3A5-747A086ADF6C Q33555184-3B30082B-8EC6-4E34-981C-39B95CF72CA9 Q33710791-9871A124-A57C-4232-ADF1-EDF1726F7816 Q33756749-446C1CC4-9715-4C00-9770-A57E25C6BA1C Q33775706-42638890-B3A8-4E7C-8A37-31561ED4F5E2 Q33969852-B0E1CD41-FD4E-4E2B-9657-B3F844083A8F Q34182362-F2885DDC-D19A-4B54-AB9F-F4C38C32C4C7 Q34394976-1D2D8E35-81DF-4170-B520-CF814F3059E5 Q34415746-E6BB08C5-F4CB-410B-90A1-D87A19A3C568 Q34420834-057007CD-325E-4663-968D-201A3257D367 Q34451739-707D4C2F-2D7D-4179-A16C-546BFBE5A855 Q34723299-EFA8D415-A574-46FF-82DD-5EF7A931A03C Q35014028-227ED3BA-CB5D-44AF-A3A4-074912604766 Q35330387-7C5280B1-B6EB-47BC-8ED5-3895E563DB3B Q35778072-84DAD344-ACD3-4B2C-A1EB-08B000360FDF Q35939580-EF54C6E1-B75D-4551-8E93-95896AF4A789 Q35970354-A4DA583E-A25D-4E4E-89E1-C5C36D7D5FE6 Q36202234-FF95A0F7-17C4-4F3F-A361-0613B124445E Q36210058-076B22A1-BB0B-4EC7-86F0-F7DD3ABEA276 Q36271608-4C98EB17-D47B-4818-892F-FFAC6ED9E14D Q36301359-60B6D08C-2A8A-4B4B-95B7-14F767FCA7B5 Q36319382-EC632269-C060-4A6F-BE9F-4DCBFB900A34 Q36464481-F9B62E53-A97A-462A-884A-F1607D512727 Q36509465-821B1981-D452-4F11-B99C-329AC06DAA5C Q36686734-D333EC87-B717-4D02-A667-6FD34CA2916D Q36924549-DBC8F055-58E6-43C0-944B-F5A22ABCD980 Q37099546-51AB7684-512E-4D48-9328-4BD635C5A6D7 Q37325722-70E304F1-3B9C-4113-BB06-5AE4615B414A Q37517378-54731BE9-13A3-44A9-8471-16850AD1501D

P2860

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

http://www.wikidata.org/entity/Q28342691

description

1989 nî lūn-bûn

@nan

1989 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Characterization of ethosuximi ...... um current in thalamic neurons

@ast

Characterization of ethosuximi ...... um current in thalamic neurons

@en

Characterization of ethosuximi ...... um current in thalamic neurons

@nl

type

label

Characterization of ethosuximi ...... um current in thalamic neurons

@ast

Characterization of ethosuximi ...... um current in thalamic neurons

@en

Characterization of ethosuximi ...... um current in thalamic neurons

@nl

prefLabel

Characterization of ethosuximi ...... um current in thalamic neurons

@ast

Characterization of ethosuximi ...... um current in thalamic neurons

@en

Characterization of ethosuximi ...... um current in thalamic neurons

@nl

P1433

Q28342691-F9AC9E53-7277-4FA3-909F-7C3DBA3C3FBC

P1476

Q28342691-AD75A605-B517-422F-8EB4-DA6BF348594A

P2093

Q28342691-2998662E-E98A-422E-AF99-4C554C818163

Q28342691-6E2D22B9-8116-4EC9-89A3-0B15F7774B21

Q28342691-BA4A1089-E970-4DA4-A3BE-A1AB162EA52C

P2860

Q28342691-138824AA-BE06-4985-ABEA-B6D2D124924D

Q28342691-15F16CCF-32F6-448D-838E-4492A68200D0

Q28342691-4FACBE3E-345E-4820-BAF9-F633043B3CDF

Q28342691-8B436A67-1503-4596-99F2-6E6D1B35D272

Q28342691-A06E9163-B51F-4305-8972-50B930B9CB31

Q28342691-E0DCBD1B-C18C-4CFB-9B52-3773307A8929

Q28342691-E19669F4-87CF-44DD-806A-6F3BB7A9C21E

Q28342691-EA22C51A-B3C5-4D36-BD49-30070AE4580B

P304

Q28342691-629A3861-9242-4983-89D1-41AC46CCE926

P31

Q28342691-6A62E380-F28D-4E58-9E41-B68F0CB826A0

P3181

Q28342691-CF811DAD-A94A-42E5-BDBA-2056D1DB4AA1

P356

Q28342691-3AAD584E-37FA-436B-9DC9-53833425FC24

P407

Q28342691-F676F9E2-39C3-4D2F-B0DA-F2CC03E80F4D

P433

Q28342691-8C6ED932-B3E2-4803-AEDD-09ACF51150F3

P478

Q28342691-EEC21302-B9B3-49E8-990C-3538F8B5CEBC

P577

Q28342691-1A1571FD-8DE2-4C6C-8CC8-6EAF5EFA7798

P698

Q28342691-3398BB83-E94F-4AEA-8FA4-BC6220A76CB2

P3181

P356

P1433

Annals of Neurology

P1476

Characterization of ethosuximi ...... um current in thalamic neurons

@en

P2093

D A Coulter

http://www.w3.org/2001/XMLSchema#string

D A Prince

http://www.w3.org/2001/XMLSchema#string

J R Huguenard

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of valproate and ethosuximide on thalamocortical excitability.

Effects of antiepileptic drugs on thalamocortical excitability.

Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones.

THE VENTRO-BASAL COMPLEX OF THE THALAMUS: TYPES OF CELLS, THEIR RESPONSES AND THEIR FUNCTIONAL ORGANIZATION.

Ethosuximide in the treatment of absence (peptit mal) seizures.

Ionic basis for the electro-responsiveness and oscillatory properties of guinea-pig thalamic neurones in vitro.

Calcium current activation kinetics in isolated pyramidal neurones of the Ca1 region of the mature guinea-pig hippocampus.

Electrophysiological properties of guinea-pig thalamic neurones: an in vitro study.

P304

582-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4559327

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.410250610

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

1989-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2545161

http://www.w3.org/2001/XMLSchema#string